{"id":"W4285591554","doi":"10.1080/13506129.2022.2093635","title":"Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group","year":2022,"lang":"en","type":"review","venue":"Amyloid","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Medicine; AL amyloidosis; Amyloidosis; Intensive care medicine; Guideline; Daratumumab; Clinical trial; Internal medicine; Oncology; Bortezomib; Pathology; Multiple myeloma; Immunology; Immunoglobulin light chain; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00277054,0.001000129,0.001818907,0.003616142,0.0004756677,0.001285867,0.002867769,0.003246612,0.009168413],"category_scores_gemma":[0.003961879,0.0004156933,0.002714388,0.00240101,0.0004890017,0.001297852,0.001006171,0.003594644,0.006657116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001735329,"about_ca_system_score_gemma":0.005336425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005351027,"about_ca_topic_score_gemma":0.007828979,"domain_scores_codex":[0.9983746,0.0004782659,0.0004295038,0.0001016699,0.0005005678,0.0001152988],"domain_scores_gemma":[0.9973464,0.0008131013,0.0004662614,0.00007343625,0.001169428,0.0001312583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001191596,0.0001180512,0.0002723025,0.01856013,0.0001841244,0.0002537997,0.0001299393,0.0003978806,0.0007970993,0.004287532,0.5009962,0.4738838],"study_design_scores_gemma":[0.0001049368,0.00004430141,0.0007903156,0.02107118,0.000244146,0.0005997529,0.00004630773,0.00009872749,0.0001562979,0.002025627,0.9748019,0.00001653137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006258788,0.9263052,0.004506441,0.02666157,0.0062692,0.001254962,0.003478318,0.0003665736,0.03053178],"genre_scores_gemma":[0.003818801,0.9206507,0.01909734,0.02587029,0.001807524,0.002019084,0.008394699,0.0001156257,0.01822598],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009168413,"threshold_uncertainty_score":0.03067142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08688512977517482,"score_gpt":0.3712326573269303,"score_spread":0.2843475275517555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}